Stericycle (SRCL) Tops Q4 EPS by 8c, FY EPS Guidance Misses

Stericycle (NASDAQ: SRCL) reported Q4 EPS of $1.03, $0.08 better than the analyst estimate of $0.95. Revenue for the quarter came in at $852.7 million versus the consensus estimate of $849.97 million.

GUIDANCE:

Stericycle sees FY2019 EPS of $3.32-$3.72, versus the consensus of $4.20. Stericycle sees FY2019 revenue of $3.408-3.533 billion, versus the consensus of $3.49 billion.

For earnings history and earnings-related data on Stericycle (SRCL) click here.

You May Also Be Interested In

• Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
• Principal Financial Group to acquire Beam Benefits, a small-business insurer
• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'